Physician

Akshay Ramachandra Kamath

According to 2025 Medicare claims, Akshay Kamath (NPI: 1528594108) practices interventional cardiology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIV OF CA (NPI: 1053304113; TIN: 680334324) and primary practice location at 95817-2201.

Kamath's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 49 traditional Medicare patients, billed 102 HCPCS/CPT codes, and received $6,566 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 448 prescription claims across 52 beneficiaries totaling $91,926 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 79 records totaling $62,128. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,059 to $91,926. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.3K$6.6K2024 Medicare payment: $6,566 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202449102$6,566

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$92K2017 Drug cost: $3,059 (USD; Tot_Drug_Cst)2018 Drug cost: $9,457 (USD; Tot_Drug_Cst)2019 Drug cost: $19,461 (USD; Tot_Drug_Cst)2020 Drug cost: $16,516 (USD; Tot_Drug_Cst)2021 Drug cost: $11,861 (USD; Tot_Drug_Cst)2022 Drug cost: $12,213 (USD; Tot_Drug_Cst)2023 Drug cost: $40,715 (USD; Tot_Drug_Cst)2024 Drug cost: $91,926 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171657$3,059
201847207$9,457
201944271$19,461
202038193$16,516
202138104$11,861
20223178$12,213
202334124$40,715
202452448$91,926

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more1212$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2123$79
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's2629$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban502,649$50,672
BrilintaTicagrelor11810$10,706
MultaqDronedarone Hcl13364$9,459
Metoprolol SuccinateMetoprolol Succinate473,260$719
Atorvastatin CalciumAtorvastatin Calcium393,354$485

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.79$62,128Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Akshay Ramachandra Kamath?

Tedicare shows public-source Medicare data for Akshay Ramachandra Kamath (NPI 1528594108), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Akshay Ramachandra Kamath have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Akshay Ramachandra Kamath?

Akshay Ramachandra Kamath is linked to REGENTS OF THE UNIV OF CA (billing NPI 1053304113) in the available physician profile data.

Does Akshay Ramachandra Kamath have Open Payments data?

Akshay Ramachandra Kamath has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.